Royalty Pharma plc Profile Avatar - Palmy Investing

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Royalty Pharma plc

Growth Rates
4.52% YoY
23.51% 3Yr
-62.54% 5Yr
-62.54% 10Yr
Key Metrics
2% TTM Yield
- - Average Days Gap
Series
0.21 DPS
1963.27% Payout Ratio
End of RPRX's Analysis
CIK: 1802768 CUSIP: G7709Q104 ISIN: GB00BMVP7Y09 LEI: - UEI: -
Secondary Listings
RPRX has no secondary listings inside our databases.